Here are five insights:
1. Researchers will assess whether pulsed electromagnetic field technology is able to decrease the rate of repaired tendons undergoing subsequent tears.
2. Additionally, the study will examine if a correlation exists between PEMF treatment and enhanced muscle strength, range of motion and decreased pain scores.
3. The study will include about 538 patients between the ages of 21 and 80, followed for 24 months post-treatment.
4. Up to 30 U.S. sites will participate in the study.
5. The RCStim is an investigational device.
More articles on devices:
Medtronic hires director of finance: 4 things to know
Camber Spine highlights 1st procedures with SPIRA-C Open Matrix Cervical Interbody — 5 notes
Can Johnson & Johnson become a 132-year-old healthcare startup? 5 quotes from CEO Alex Gorsky
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
